You are here
InspireMD to Report Third Quarter 2018 Financial Results and Provide Business Update on Tuesday, November 6
Conference Call Scheduled for 8am Eastern Time
TEL AVIV, Israel, Oct. 30, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, November 6, 2018, to discuss financial results for the three and nine months ended September 30, 2018, and provide a corporate update.
|Conference Call & Webcast:|
|Tuesday, November 6 @ 8:00am Eastern Time|
|Within the US:||877-451-6152|
|Outside the US:||201-389-0879|
|Replays, Available through November 20:|
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes.
InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS.
Chief Financial Officer
LifeSci Advisors, LLC